Skip to main content

$0.125 (0%)

High

$0.13

Low

$0.12

Trades

20

Turnover

$48,049

Volume

400,697
30 June 2023 at 3:57pm
Register to track CYP and receive email alerts.
Subject
CYP Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease

CYP Ann: Appendix 3X - Janine Rolfe

CYP Ann: Appointment of Ms Janine Rolfe to the Cynata Board

CYP Ann: Preclinical study in coronary artery disease published

CYP Ann: Appendix 4G

CYP Ann: Corporate Governance Statement

CYP Ann: Appendix 4E & Annual Report

CYP Ann: Pipeline Update Following Strategic Portfolio Review

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Notice of Allowance for Cynata US Patent

CYP Article: Why this CEO brainstorms while sitting on a surfboard

CYP Ann: Further data supports potency of Cynata MSCs

CYP Ann: Cynata Adds New Site for MEND Clinical Trial

CYP Ann: FDA Clears Cynata IND for Phase 2 Trial in GvHD

CYP Ann: Notification of cessation of securities - CYP

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cynata Advances Clinical Trial in Diabetic Foot Ulcers

CYP Ann: Updated Investor Presentation

CYP Ann: Notice of Allowance for Cynata Chinese Patent

CYP Ann: Appendix 4D & Half-Year Financial Statements

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cynata Receives Decision to Grant a Patent in Japan

CYP Ann: Cynata Receives $832,677 R&D Tax Incentive Refund

CYP Ann: FUJIFILM Cellular Dynamics Executes Manufacturing Agreement

CYP Ann: Cynata Commences DFU Clinical Trial

CYP Ann: Change of Registry Address

CYP Ann: Appendix 3Y- Dr Stewart Washer

CYP Ann: Appendix 3Y - Dr Geoffrey Brooke

CYP Ann: Site Initiation Visit Completed for CYP DFU Clinical Trial

CYP Ann: Results of Annual General Meeting

CYP Ann: AGM Presentations

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cynata Receives US$5m Fujifilm Fee

CYP Ann: Annual Report to shareholders

CYP Ann: Letter to Shareholders & Notice of Annual General Meeting

CYP Ann: Notification regarding unquoted securities - CYP

CYP Ann: DSMB Recommends Continuation of Cynata's MEND Trial

CYP Ann: Cynata Enters into a New Strategic Partnership with Fujifilm

CYP Ann: CYP Preclinical Heart Attack Study Published in Cytotherapy

CYP Ann: Date of AGM and Closing Date for Director Nominations

CYP Ann: Further Patents for Cynata Unique Cymerus Technology

CYP Ann: Further Canadian Patent for Cynata

CYP Ann: Appendix 4G

CYP Ann: Appendix 4E & Annual Report

CYP Ann: Cynata Receives Notice of Allowance from US Patent Office

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cynata Appoints Dr Jolanta Airey Chief Medical Officer

CYP Ann: Change of Registered Office

CYP Ann: Ethics Approval for Cynata's Clinical Trial in DFU

CYP Ann: Progress Toward Clinical Trial in Diabetic Foot Ulcers

Register to track CYP and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX